August 26, 2026
KENNEWICK, WA - August 26, 2026 -
Michael Turner, M.D., announced the availability of physician-led testosterone services for individuals across additional service areas, marking an operational expansion of access to hormone-related medical care within his outpatient practice. The announcement reflects a service availability update intended to inform the public about access to medically supervised testosterone-related consultations delivered through an established clinical framework.
The testosterone services offered through Michael Turner, M.D. are provided within a physician-directed model that emphasizes evaluation, documentation, and ongoing medical oversight. With the expanded availability, individuals in newly supported service areas may now access consultations through telemedicine appointments, supporting physician involvement in hormone-related medical care without geographic or logistical barriers.
According to the practice, testosterone services are delivered through a structured consultation process that includes medical history review, clinical discussion, and physician supervision. The service offering is positioned within an outpatient medical setting and operates under licensed medical standards. The expanded availability does not introduce new therapies or treatment claims but extends access to existing physician-led services for a broader population.
The practice indicated that the testosterone service is intended for adult men seeking physician involvement in the evaluation and management of hormone-related considerations. Rather than providing generalized wellness programs or over-the-counter solutions, the service emphasizes direct engagement with a licensed physician. Each patient interaction is conducted within a documented medical relationship, with care decisions guided by clinical review and ongoing oversight.
Dr. Michael Turner, M.D., founder of the practice, stated that the expansion reflects a broader effort to improve access to physician-guided services that require medical supervision. “The availability of testosterone-related services across additional areas allows individuals to engage with a physician-led care model that prioritizes evaluation and follow-up,” said Dr. Turner. “This update is focused on access and continuity rather than changes to clinical scope.”
Testosterone services through the practice are delivered through scheduled telemedicine consultations, allowing patients in newly supported areas to consult with Dr. Turner without extensive travel. This delivery model is intended to support accessibility while maintaining consistent medical oversight within a single medical practice.
The practice noted that physician involvement remains central to how testosterone services are offered. Consultations are structured to allow for discussion of medical history, relevant laboratory data when applicable, and individualized care planning within the bounds of outpatient medical practice. Follow-up scheduling and ongoing communication are incorporated into the service model to support continuity rather than isolated encounters.
In addition to expanding access, the practice highlighted that the testosterone service is delivered within a framework emphasizing patient education and informed decision-making. Consultations are designed to provide individuals with clarity regarding the scope of physician involvement and the structure of ongoing care. This approach aligns with broader trends in outpatient medicine that prioritize transparency and patient understanding in medically supervised services.
The expanded availability also supports individuals seeking predictable access to physician-led care amid evolving healthcare delivery models. By offering scheduled appointments within a defined outpatient structure, the testosterone service provides an option for patients who prefer consistent physician engagement rather than fragmented or episodic care experiences. The practice indicated that maintaining this structure is a priority as service reach increases.
Michael Turner, M.D., has provided physician-led medical services since 2019, with a clinical focus that includes men’s health, hormone-related care, and integrative medical services. The practice operates with a limited patient model designed to support individualized attention and ongoing physician involvement. The expanded availability of testosterone services reflects an effort to extend this care model to additional service areas without altering its clinical framework.
The announcement does not include efficacy claims, outcome guarantees, or comparative statements. Instead, it reflects an operational update allowing individuals in newly supported areas to access physician-led testosterone consultations through the practice’s established intake and scheduling process. Eligibility and care decisions remain subject to medical review and standard clinical considerations.
The practice also indicated that standardized intake procedures and documentation protocols are maintained across all service areas to support consistency in care delivery. As geographic reach expands, the testosterone service continues to operate within the same administrative and clinical workflows used throughout the practice. This operational consistency is intended to preserve continuity and reliability regardless of patient location.
As interest in physician-supervised hormone-related care continues to grow, outpatient medical practices nationwide are evaluating how telemedicine and structured consultation models can support broader access. The expanded availability of testosterone services through Michael Turner, M.D., reflects this shift while maintaining physician accountability and patient-centered engagement.
Individuals in newly supported service areas may now request consultations for testosterone-related services through the practice’s standard intake process, subject to medical appropriateness and scheduling availability. The expansion is intended to improve access without modifying the scope, regulatory standards, or physician oversight that define the service offering.
For more information about Michael Turner, M.D., and available testosterone services, visit https://www.michaelturnermd.com
###
For more information about Dr. Michael K Turner MD, contact the company here:
Michael Turner M.D.
Michael Turner
509-349-3010
office@michaelturnermd.com
8101 W Grandridge Blvd Suite 120 B, Kennewick, WA 99336